These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22526387)

  • 1. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
    Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H; Kaneda T; Kida Y; Kaneko M; Fujii H; Hayashi M; Tomii K; Tada K; Suzuki Y; Karino T
    Kansenshogaku Zasshi; 2011 Nov; 85(6):644-51. PubMed ID: 22250455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
    Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
    Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlations between drug plasma concentration and adverse effects in patients treated with itraconazole for pulmonary aspergilloma].
    Maesaki S; Hashiguchi K; Tomiyama Y; Sasaki E; Miyazaki H; Miyazaki Y; Higashiyama Y; Tomono K; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 1999 Nov; 37(11):875-9. PubMed ID: 18217308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases.
    Nam HS; Jeon K; Um SW; Suh GY; Chung MP; Kim H; Kwon OJ; Koh WJ
    Int J Infect Dis; 2010 Jun; 14(6):e479-82. PubMed ID: 19910234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis.
    Nakamura Y; Matsumoto K; Sato A; Morita K
    J Infect Chemother; 2020 Feb; 26(2):170-174. PubMed ID: 31481305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole].
    Yasuda S; Ohnishi R; Suzuki T; Sano K; Kato T
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):985-90. PubMed ID: 19994592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
    Fujita M; Tao Y; Kajiki A; Ouchi H; Harada E; Ikegame S; Matsumoto T; Uchino J; Watanabe K; Nakanishi Y
    J Infect Chemother; 2012 Oct; 18(5):668-74. PubMed ID: 22350405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of pulmonary aspergilloma successfully treated with transbronchial intracavitary itraconazole].
    Tani S; Tomioka H; Tsuchimoto K; Kaneda T; Kubota M; Kaneko M; Fujii H
    Nihon Kokyuki Gakkai Zasshi; 2008 Dec; 46(12):997-1002. PubMed ID: 19195200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
    Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
    Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of pulmonary aspergilosis, which deteriorated with generic itraconazole].
    Saito W; Shishikura Y; Nishimaki K; Kikuchi T; Sasamori K; Kikuchi Y; Miki H
    Kansenshogaku Zasshi; 2014 Jul; 88(4):469-73. PubMed ID: 25199382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Itraconazole-induced hypokalemia in a patient with pulmonary aspergilloma].
    Sasaki E; Maesaki S; Kawamura S; Kakeya H; Ohno H; Hirakata Y; Tomono K; Ohzono Y; Tashiro T; Kohno S
    Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):36-40. PubMed ID: 10087874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Kiyokawa H; Nakashima R; Takafuji S; Suzuki Y; Ito A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):448-54. PubMed ID: 18592989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole in chronic cavitary pulmonary aspergillosis: a randomised controlled trial and systematic review of literature.
    Agarwal R; Vishwanath G; Aggarwal AN; Garg M; Gupta D; Chakrabarti A
    Mycoses; 2013 Sep; 56(5):559-70. PubMed ID: 23496375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units.
    Hagihara M; Kasai H; Umemura T; Kato T; Hasegawa T; Mikamo H
    J Infect Chemother; 2011 Apr; 17(2):224-30. PubMed ID: 20799049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus.
    Mochizuki M; Murase S; Takahashi K; Shimada S; Kume H; Iizuka T; Fukuda M
    Nihon Ishinkin Gakkai Zasshi; 2000; 41(1):33-9. PubMed ID: 10660641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole for invasive fungal infection with pediatric malignancies.
    Kobayashi R; Suzuki D; Yasuda K; Kobayashi K
    Pediatr Int; 2010 Oct; 52(5):707-10. PubMed ID: 20337979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study].
    Kawano I; Matsumoto K; Jiromaru T; Jinnochi F; Semba Y; Sugio T; Sakamoto K; Saito N; Yoshida S; Henzan H; Takase K; Morita K; Eto T
    Rinsho Ketsueki; 2016; 57(12):2475-2480. PubMed ID: 28090013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of intravenous injecting itraconazole as empirical antifungal therapy for patients with hematological malignancies].
    Luo CW; DU X; Guo R; Weng JY; Lu ZS; Wu SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):1000-4. PubMed ID: 22931672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.